[Screening and prevention of toxic optic neuropathies due to anti-mycobacterium therapies: proposal of recommendations]. / Dépistage et prévention des neuropathies optiques toxiques aux anti-mycobactériens : proposition de recommandations.
J Fr Ophtalmol
; 45(5): 495-503, 2022 May.
Article
en Fr
| MEDLINE
| ID: mdl-35430117
ABSTRACT
While treatment of pulmonary infections by Mycobacterium tuberculosis is currently only rarely the cause of iatrogenic complications, treatment of atypical mycobacterial infections often requires prolonged treatment duration, which can lead to toxic optic neuropathies. This review summarizes the indications for such prolonged treatment and risk factors for toxic optic neuropathies when using ethambutol, isoniazid and/or linezolid and proposes customized screening recommendations.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
/
3_ND
Problema de salud:
1_doencas_nao_transmissiveis
/
3_neglected_diseases
/
3_tuberculosis
Asunto principal:
Etambutol
/
Neuropatía Óptica Tóxica
Tipo de estudio:
Diagnostic_studies
/
Guideline
/
Risk_factors_studies
/
Screening_studies
Límite:
Humans
Idioma:
Fr
Revista:
J Fr Ophtalmol
Año:
2022
Tipo del documento:
Article